Metabolic requirements for the development of hemadsorption activity and virus formation in BHK-21 cells infected with Newcastle disease virus.
Differential effect of various metabolic inhibitors on the development of hemadsorption activity and virus formation in cells infected with Newcastle disease virus (NDV) was investigated. It was found that, in BHK-21 cells infected with NDV, cycloheximide did not prevent the development of hemadsorption activity, whereas protein synthesis and virus formation by the cell were rapidly inhibited by the drug. When the drug was added to the culture at 4.5 h after infection or later, hemadsorption activity of the cell continued to develop normally for about 1 h. Similar increase in hemadsorption activity was found in cells which were treated with anti-NDV serum (to neutralize their hemadsorption activity) and then washed and incubated with cycloheximide. However, when cells were treated with the drug early in the infection (1.5 or 3.0 h), they did not show any detectable hemadsorption reaction throughout the infection. In contrast to cycloheximide, iodoacetate added to the culture together with sodium azide inhibited completely both the development of hemadsorption activity and the formation of progeny virus. These results suggest that the change of cell surface to become hemadsorptive may depend upon the energy generating system but not upon de novo synthesis of protein, whereas production of infectious virus may require continuous synthesis of protein.
D000818:Animals; D001386:Azides / Q000494:pharmacology; D002460:Cell Line / Q000382:microbiology; D002462:Cell Membrane / Q000187:drug effects; D002645:Chickens / Q000276:immunology; D006224:Cricetinae; D003513:Cycloheximide / Q000494:pharmacology; D004912:Erythrocytes / Q000276:immunology; D006168:Guinea Pigs / Q000276:immunology; D006382:Hemadsorption / Q000187:drug effects; D006386:Hemagglutination Tests; D006389:Hemagglutinins, Viral / Q000032:analysis; D007106:Immune Sera; D007461:Iodoacetates / Q000494:pharmacology; D007668:Kidney; D009439:Neuraminidase / Q000032:analysis; D009522:Newcastle disease virus / Q000201:enzymology / Q000254:growth & development* / Q000276:immunology; D014176:Protein Biosynthesis; D011817:Rabbits / Q000276:immunology; D013997:Time Factors; D014779:Virus Replication
D001386:Azides; D006389:Hemagglutinins, Viral; D007106:Immune Sera; D007461:Iodoacetates; D003513:Cycloheximide; D009439:Neuraminidase